Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report

Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report

ABSTRACT: Objectives: The pharmacokinetics of vancomycin and meropenem in patients treated with continuous online hemodiafiltration (OL-HDF) are not well understood. Case: We evaluated dialytic clearance and serum concentrations of vancomycin and meropenem by OL-HDF in a critically ill patient with...

Full description

Bibliographic Details
Main Authors:	Yoko Niibe, Tatsuya Suzuki, Shingo Yamazaki, Takaaki Suzuki, Noriyuki Hattori, Taka-aki Nakada, Itsuko Ishii
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Journal of Global Antimicrobial Resistance
Subjects:	Continuous infusion Antibiotics Critical care
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716523000346

Similar Items

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
by: Hui-Ying Zhao, et al.
Published: (2017-01-01)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
by: Romain Garreau, et al.
Published: (2021-10-01)

Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
by: Milo Gatti, et al.
Published: (2023-10-01)

Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review
by: Marta Alonso-Moreno, et al.
Published: (2021-07-01)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i>
by: Pier Giorgio Cojutti, et al.
Published: (2020-08-01)

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study
by: Jinhui Xu, et al.
Published: (2022-08-01)

Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode
by: Xiangqing Song, et al.
Published: (2022-07-01)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
by: Manon Tauzin, et al.
Published: (2019-05-01)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022-08-01)

Vancomycin induced acute kidney injury: a review of the literature
by: Kerry Anne Rambaran, et al.
Published: (2016-07-01)

Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials
by: Ming-Ying Ai, et al.
Published: (2024-03-01)

Case report: Successful experience using continuous infusion of meropenem in a geriatric patient with hip fracture complicated by sepsis
by: Assiya Kadralinova, et al.
Published: (2023-04-01)

Pharmacokinetic Analysis of Meropenem and Piperacillin in Critically-Ill Patients Requiring Continuous Ven-Venous Hemodiafiltration
by: Brandon Ferlas, et al.
Published: (2015-01-01)

Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
by: Erin Chung, et al.
Published: (2021-04-01)

Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration.
by: Niels Westra, et al.
Published: (2019-01-01)

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
by: Thomas De Corte, et al.
Published: (2023-04-01)

Meropenem PK/PD Variability and Renal Function: “We Go Together”
by: Jacopo Angelini, et al.
Published: (2023-08-01)

Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients
by: Hsin Lin, et al.
Published: (2016-07-01)

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Pengxiang Zhou, et al.
Published: (2022-10-01)

Meropenem pharmacokinetics during relapsing peritonitis due to ESBL‐producing Enterobacteriaciae in a liver transplant recipient
by: Kensuke Shoji, et al.
Published: (2019-11-01)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
by: Maluangnon C, et al.
Published: (2022-12-01)

Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Frontiers Production Office
Published: (2022-12-01)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
by: Pier Giorgio Cojutti, et al.
Published: (2021-12-01)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
by: Kazuhiro Ishikawa, et al.
Published: (2023-06-01)

Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
by: Carla Troisi, et al.
Published: (2023-02-01)

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study
by: Yohei Komaru, et al.
Published: (2023-05-01)

Continuous wound infusion as an alternative to continuous epidural infusion for postoperative analgesia in renal transplant surgery: A prospective randomized controlled trial
by: Vinitha Narayan, et al.
Published: (2021-01-01)

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023-06-01)

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
by: Guangna Cao, et al.
Published: (2022-03-01)

Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model
by: Satoshi Yoshikawa, et al.
Published: (2023-11-01)

Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration
by: Yuriko Ito, et al.
Published: (2023-05-01)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
by: Pier Giorgio Cojutti, et al.
Published: (2022-01-01)

Optimizing Betalactam Clinical Response by Using a Continuous Infusion: A Comprehensive Review
by: Sylvain Diamantis, et al.
Published: (2023-06-01)

Intermittent infusion hemodiafiltration is associated with improved survival compared to hemodialysis
by: Masanori Abe, et al.
Published: (2024-03-01)

The effectiveness of continuous venovenous hemodiafiltration in phenobarbital intoxication
by: Yasemin Çoban, et al.
Published: (2018-01-01)

Effect of continuous hemodiafiltration using an AN69ST membrane in patients with sepsis
by: Akihito Tanaka, et al.
Published: (2017-03-01)

Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study
by: Passara Maimongkol, et al.
Published: (2022-07-01)

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
by: Lore Thijs, et al.
Published: (2022-05-01)

Comparison of Endostar continuous versus intermittent intravenous infusion in combination with first‐line chemotherapy in patients with advanced non‐small cell lung cancer
by: Yuan Cheng, et al.
Published: (2019-07-01)

Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
by: Sarah Fawaz, et al.
Published: (2020-06-01)